20Slash20 Inc., the creator of The Eye Drink, will be among the companies featured at the upcoming Disruptive Growth & Life Sciences Conference hosted by Moody Capital Solutions. The event, scheduled for 2026, will highlight innovative companies across various sectors, including life sciences and disruptive technologies. 20Slash20's participation underscores the growing importance of preventive health solutions in response to modern lifestyle challenges.
The Eye Drink is touted as the world's first clinically inspired, ready-to-drink functional beverage specifically formulated to minimize ocular issues caused by prolonged screen time. With the average person spending increasing hours on digital devices, the product aims to combat screen-induced dry eyes and potential macular damage. The beverage incorporates science-backed nutrients based on the AREDS 2 studies, along with vegan-friendly triglyceride-formed Omega-3, to support visual performance and ocular comfort.
The company's approach to modernizing preventive eyecare involves transforming clinical science into a simple, daily habit. By leveraging direct-to-consumer channels, professional medical affiliates, and natural product retail stores, 20Slash20 seeks to make eye health accessible and enjoyable. The Eye Drink represents a convergence of nutrition and technology, offering a practical solution for the digital age.
The conference, organized by Moody Capital Solutions, an independent investment bank with over four decades of experience, will provide a platform for companies like 20Slash20 to connect with investors and industry stakeholders. Moody Capital is recognized as a market leader in rights offerings and offers a range of services including capital raising and M&A advisory.
IBN, a financial news and publishing company, will provide comprehensive coverage of the event. Through its custom-built portal, IBN will offer summaries of participating companies, enabling investors to evaluate each opportunity with one-click access to research tools and websites. IBN will also leverage social media and syndicated articles to maximize the visibility of the conference.
The inclusion of 20Slash20 at this conference is significant for the eye care industry and the broader health and wellness sector. As digital device usage continues to rise, the demand for preventive solutions like The Eye Drink is expected to grow. This event provides a valuable opportunity for 20Slash20 to attract potential partners and investors who recognize the potential of this niche market.
For more information about The Eye Drink, visit the company's website at theeyedrink.com. To register for the conference, go to https://moodycapital.com/conference/. For IBN's coverage of the event, visit https://ibn.fm/MoodyCapital2026Conference.
